Results 121 to 130 of about 3,454 (177)
Can the dexamethasone intravitreal implant Ozurdex be safely administered in an out-of-operating room setting? [PDF]
J Drug Assess, 2020 Cidad-Betegón MDP +9 more
europepmc +1 more source
Modified insertion technique for a sustained-release dexamethasone intravitreal implant (Ozurdex®). [PDF]
Am J Ophthalmol Case Rep, 2020 Lee DH, Chan CK.
europepmc +1 more source
Comment on “Intravitreal dexamethasone implants for diabetic macular edema”
International Journal of Ophthalmology, 2018 Dan Călugăru +2 more
openaire +3 more sources
Dexamethasone Intravitreal Implant Injection in Eyes with Comorbid Hypotony. [PDF]
Ophthalmol Retina, 2019 Kong X, Psaras C, Stewart JM.
europepmc +1 more source
INTRAVITREAL DEXAMETHASONE IMPLANTATION IN THE MANAGEMENT OF UVEITIS
Научное обозрение. Медицинские науки (Scientific Review. Medical Sciences)openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Reverse engineering the Ozurdex dexamethasone intravitreal implant
International Journal of Pharmaceutics, 2023Ozurdex is a biodegradable implant formulated for sustained-release delivery of the corticosteroid dexamethasone to the posterior segment of the eye. The small, rod-shaped implant is administered directly to the vitreous using a dedicated applicator, and releases drug for up to 6 months after administration.
Mark A, Costello +7 more
openaire +2 more sources